This is a $374,923 cost-plus-fixed-fee delivery order contract awarded by the National Institute on Drug Abuse (NIDA) to The Emmes Company LLC, a global clinical research organization based in Rockville, Maryland. The contract is for the "PHARMACIST-INTEGRATED MODEL OF MEDICATION TREATMENT FOR OPIOID USE DISORDER" project, which will run from December 1, 2023 to March 31, 2025. This task order (75N95024F00001, TO17) is part of NIDA's $31 million Indefinite Delivery Vehicle (IDV) contract for data, statistics, and clinical trial support services. The contract has no set-aside designation, reflecting Emmes' extensive experience supporting complex biomedical research initiatives for federal agencies, particularly the National Institutes of Health (NIH) and its various institutes.
Generated 3/14/25, 9:53 AM